WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
WX was delisted on the 10th of December, 2015.
147 hedge funds and large institutions have $2.39B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 67 increasing their positions, 47 reducing their positions, and 31 closing their positions.
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
43% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 47
18% more capital invested
Capital invested by funds: $2.03B → $2.39B (+$363M)
9% more call options, than puts
Call options by funds: $1.18M | Put options by funds: $1.08M
11% less funds holding
Funds holding: 165 → 147 (-18)
48% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$106M |
| 2 |
MICM
Matthews International Capital Management
San Francisco,
California
|
+$62.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$44M |
| 4 |
Millennium Management
New York
|
+$32.3M |
| 5 |
Jennison Associates
New York
|
+$25.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$84.3M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$46M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$36.5M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$26.2M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$16.6M |
WX Hedge Fund Activity: Q1 2015 in Review
147 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q1 2015, worth a combined $2.39B — up 18% from $2.03B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of WX and 16 opened new positions — a net loss of 15 holders — while 47 trimmed existing stakes and 67 added.
The largest buyer was Wellington Management Group, adding an estimated $106M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $84.3M.
- 147 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q1 2015, down from 165 in Q4 2014.
- Funds reported $2.39B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q1 2015, up 18% quarter-over-quarter.
- 16 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q1 2015 and 31 closed out, a net change of -15 holders.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q1 2015 was Wellington Management Group, an estimated $106M added.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q1 2015 was Columbia Wanger Asset Management, an estimated $84.3M sold.
Based on aggregated 13F filings for Q1 2015.